Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells
Breast cancer is the most diagnosed cancer in women, and symptomatic brain metastases (BCBMs) occur in 15–20% of metastatic breast cancer cases. Despite technological advances in radiation therapy (RT), the prognosis of patients is limited. This has been attributed to radioresistant breast cancer st...
Main Authors: | Katharina Hintelmann, Cordula Petersen, Kerstin Borgmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/1/211 |
Similar Items
-
Selecting the Appropriate Radiation Therapy Technique for Extensive Brain Metastases from Tens to Hundreds: Should the Latest Technique Always Be the Best Option?
by: Seok Ho Lee
Published: (2023-10-01) -
Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review
by: Angelo Luciano, et al.
Published: (2023-11-01) -
PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
by: Ilinca Popp, et al.
Published: (2023-06-01) -
Single-fraction SRS and multiple-fraction SRT for brain metastases from colorectal cancer
by: Yong Li, et al.
Published: (2022-12-01) -
Application of piecewise VMAT technique to whole-brain radiotherapy with simultaneous integrated boost for multiple metastases
by: Yuan Xu, et al.
Published: (2022-05-01)